Dexamethasone reduces cisplatin-induced hair cell damage by inducing cisplatin resistance through metallothionein-2
- 14 August 2024
- journal article
- research article
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 94 (4) , 561-569
Abstract
Purpose Hair cell damage is a common side effect caused by the anticancer drug cisplatin (CDDP), which reduces patient quality of life. One CDDP resistance mechanism that occurs in recurrent cancers is heavy metal detoxification by metallothionein-2 (mt2). Here, we show that in zebrafish larvae, dexamethasone (DEX) reduces CDDP-induced hair cell damage by enhancing mt2 expression. Methods Transgenic zebrafish (cldn: gfp; atoh1: rfp) that express green and red fluorescent proteins in neuromasts and hair cells, respectively, were used. The zebrafish were pretreated with DEX at 52 h post-fertilization (hpf) for 8 h, followed by CDDP treatment for 12 h. The lateral line hair cells of CDDP-treated zebrafish at 72 hpf were observed by fluorescence microscopy. Results Reporting odds ratio (ROR) analysis using an adverse event database indicated an association between a decrease in CDDP-induced ototoxicity and DEX as an antiemetic treatment for cancer chemotherapy. Pretreatment with DEX protected 72 hpf zebrafish hair cells from CDDP-induced damage. The expression of mt2 mRNA was significantly increased by the combination of 10 µM DEX with CDDP. Gene editing of mt2 reversed the protective effect of DEX against CDDP-induced damage in hair cells. Conclusion DEX protects hair cells from CDDP-induced damage through increased mt2 expression, which is a resistance mechanism for platinum-based anticancer drugs.Keywords
All Related Versions
This publication has 41 references indexed in Scilit:
- Identification of mechanisms of action of bisphenol a-induced human preadipocyte differentiation by transcriptional profilingObesity, 2014
- The protective effects of intratympanic dexamethasone and vitamin E on cisplatin-induced ototoxicity are demonstrated in ratsMedical Oncology, 2010
- Evidence that Cisplatin-induced Auditory Damage is Attenuated by Downregulation of Pro-inflammatory Cytokines Via Nrf2/HO-1Journal of the Association for Research in Otolaryngology, 2008
- Molecular multi‐effect screening of environmental pollutants using the MolDarTEnvironmental Toxicology, 2008
- The protective effect of intratympanic dexamethasone on cisplatin‐induced ototoxicity in guinea pigsOtolaryngology–Head and Neck Surgery, 2007
- Nuclear metallothionein expression correlates with cisplatin resistance of ovarian cancer cells and poor clinical outcomeVirchows Archiv, 2007
- Antioxidant protection in a new animal model of cisplatin-induced ototoxicityHearing Research, 2004
- Metallothionein: the multipurpose proteinCellular and Molecular Life Sciences, 2002
- Cortisol induction of metallothionein in primary culture of rainbow trout hepatocytesJournal of Cellular Physiology, 1989
- Metallothionein-mediated cisplatin resistance in human ovarian carcinoma cellsCancer Chemotherapy and Pharmacology, 1987